SHSE:688217 (China)
Â
Class A
Â¥
14.17
(-0.91%)
Sep 12
Business Description
Shanghai Rightongene Biotechnology Co Ltd
ISIN : CNE100005212
Share Class Description:
SHSE:688217: Class ACompare
Compare
Traded in other countries / regions
688217.China IPO Date
2021-05-17Description
Shanghai Rightongene Biotechnology Co Ltd is engaged in the research and development, production, sales, scientific research and testing services of in vitro diagnostic products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.55 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -2.08 | |||||
| Interest Coverage | 3.07 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.64 | |||||
| Beneish M-Score | -2.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.7 | |||||
| 3-Year EBITDA Growth Rate | -27.3 | |||||
| 3-Year EPS without NRI Growth Rate | -58.4 | |||||
| 3-Year Book Growth Rate | 3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 59.02 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 20.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.12 | |||||
| 9-Day RSI | 42.94 | |||||
| 14-Day RSI | 41.85 | |||||
| 6-1 Month Momentum % | -41.39 | |||||
| 12-1 Month Momentum % | -60.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.6 | |||||
| Quick Ratio | 10.38 | |||||
| Cash Ratio | 5.1 | |||||
| Days Inventory | 321.17 | |||||
| Days Sales Outstanding | 267.76 | |||||
| Days Payable | 99.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.26 | |||||
| Dividend Payout Ratio | 0.6 | |||||
| Forward Dividend Yield % | 1.26 | |||||
| 5-Year Yield-on-Cost % | 1.26 | |||||
| 3-Year Average Share Buyback Ratio | -10.3 | |||||
| Shareholder Yield % | -0.33 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.62 | |||||
| Operating Margin % | 0.82 | |||||
| Net Margin % | 0.35 | |||||
| FCF Margin % | -4.11 | |||||
| ROE % | 0.1 | |||||
| ROA % | 0.09 | |||||
| ROIC % | 0.15 | |||||
| 3-Year ROIIC % | -19.58 | |||||
| ROC (Joel Greenblatt) % | -2.13 | |||||
| ROCE % | -1.22 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 713 | |||||
| Forward PE Ratio | 56.68 | |||||
| PE Ratio without NRI | 47.38 | |||||
| PS Ratio | 2.98 | |||||
| PB Ratio | 0.85 | |||||
| Price-to-Tangible-Book | 0.91 | |||||
| Price-to-Operating-Cash-Flow | 24.05 | |||||
| EV-to-EBIT | -49.38 | |||||
| EV-to-EBITDA | -49.38 | |||||
| EV-to-Revenue | 2.28 | |||||
| EV-to-FCF | -55.5 | |||||
| Price-to-Graham-Number | 1.38 | |||||
| Price-to-Net-Current-Asset-Value | 1.95 | |||||
| Price-to-Net-Cash | 6.16 | |||||
| Earnings Yield (Greenblatt) % | -2.03 | |||||
| FCF Yield % | -1.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Rightongene Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 265.436 | ||
| EPS (TTM) (Â¥) | 0.02 | ||
| Beta | 1.37 | ||
| Volatility % | 39.29 | ||
| 14-Day RSI | 41.85 | ||
| 14-Day ATR (Â¥) | 0.638326 | ||
| 20-Day SMA (Â¥) | 14.584 | ||
| 12-1 Month Momentum % | -60.54 | ||
| 52-Week Range (Â¥) | 12.38 - 43.05 | ||
| Shares Outstanding (Mil) | 55.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Rightongene Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Rightongene Biotechnology Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Rightongene Biotechnology Co Ltd Frequently Asked Questions
What is Shanghai Rightongene Biotechnology Co Ltd(SHSE:688217)'s stock price today?
The current price of SHSE:688217 is ¥14.17. The 52 week high of SHSE:688217 is ¥43.05 and 52 week low is ¥12.38.
When is next earnings date of Shanghai Rightongene Biotechnology Co Ltd(SHSE:688217)?
The next earnings date of Shanghai Rightongene Biotechnology Co Ltd(SHSE:688217) is .
Does Shanghai Rightongene Biotechnology Co Ltd(SHSE:688217) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Rightongene Biotechnology Co Ltd(SHSE:688217) is 1.26% (As of Today), Highest Dividend Payout Ratio of Shanghai Rightongene Biotechnology Co Ltd(SHSE:688217) was 2.57. The lowest was 0.6. And the median was 2.57. The  Forward Dividend Yield % of Shanghai Rightongene Biotechnology Co Ltd(SHSE:688217) is 1.26%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers